Pneumococcal arthritis and monoclonal gammopathy of undetermined significance

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 3, 1997, Pages 342-

  Korman, T M ^a,d   Brodie, G N ^b   Grayson, M L ^c  

^a Microbiology and Infectious Diseases   (Australia)

^b Medical Oncology ^*

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN; INOTROPIC AGENT; PARAPROTEIN; PENICILLIN G;

AGED; ARTICLE; BACTERIAL ARTHRITIS; CASE REPORT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOELECTROPHORESIS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIAE; SYNOVIAL FLUID;

EID: 0030745989     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb01992.x     Document Type: Article

References (6)

1. Cuesta M, Bernad M, Espinosa A, Herranz P, Martin Mola E, Gijon Banos J. Pneumococcal septic arthritis as the first manifestation of multiple myeloma. Clin Exp Rheumatol 1992; 10: 483-4.
2. Kyle RA. Current concepts on monoclonal gammopathies. Aust NZJ Med 1992; 22: 291-302.
3. Twomey JJ. Infections complicating multiple myeloma and chronic lymphocytic leukemia. Arch Intern Med 1973; 132: 562-5.
4. Ucci G, Riccardi A, Luoni R, Ascari E. Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases. J Intern Med 1993; 234: 165-73.
5. Yap PL. Prevention of infection in patients with B cell defects: focus on intravenous immunoglobulin. Clin Infect Dis 1993; 17 (Suppl. 2): S372-5.
6. Chapel HM, Lee M, Hargreaves R, Pamphilon DH, Prentice AG. Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK group for immunoglobulin replacement therapy in multiple myeloma. Lancet 1994; 343: 1059-62.